Alma Mater Studiorum—Universita di Bologna has a total of 13 patent applications. It increased the IP activity by 0.0%. Its first patent ever was published in 2015. It filed its patents most often in United States. Its main competitors in its focus markets pharmaceuticals, biotechnology and measurement are WUERFEL WOLFGANG, UNIV SAITAMA MEDICAL and INST IMMUNOLOGII I TERAPII DOSWIADCZALNEJ PAN.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 13 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology | |
#3 | Measurement | |
#4 | Computer technology | |
#5 | Foods and drinks | |
#6 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides | |
#4 | Microorganisms | |
#5 | Enzymes | |
#6 | Analysing materials | |
#7 | Electric digital data processing | |
#8 | Diagnosis and surgery | |
#9 | Measuring mechanical vibrations | |
#10 | Healthcare informatics |
# | Name | Total Patents |
---|---|---|
#1 | Ciani Elisabetta | 4 |
#2 | Laccone Franco | 3 |
#3 | Rodia Maria | 1 |
#4 | Lugli Stefano | 1 |
#5 | Fuchs Claudia | 1 |
#6 | Tonni Laura | 1 |
#7 | Grandi Michelangelo | 1 |
#8 | Masetti Guido | 1 |
#9 | Soavi Francesca | 1 |
#10 | Tregnaghi Giovanni | 1 |
Publication | Filing date | Title |
---|---|---|
US2019083454A1 | Perinatal treatment with a flavonoid agonist of the TrkB receptor for BDNF rescues neurogenesis and behavior in the Ts65Dn mouse model of DS | |
US2019338483A1 | Penetrometer | |
US2017118881P1 | Cherry tree named ‘PA6UNIBO’ | |
US2017248556A1 | Piezoelectric sensor, system and method for monitoring the integrity of structures | |
US2017160549A1 | Augmented reality glasses for medical applications and corresponding augmented reality system |